Trial Profile
The effect of combination therapy with Alendronate and Eldecalcitol for glucocorticoid induced osteoporosis - switch from Alfacalcidol to Eldecalcitol
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jul 2016
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Alfacalcidol (Primary) ; Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 17 Jan 2013 New trial record